PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-06-07

Date Title Company
07-Jun-2022 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
07-Jun-2022 Longer-term Data from CARTITUDE-1 Study Demonstrate Continued Deep and Durable Responses to CARVYKTI™ (ciltacabtagene autoleucel) in Heavily Pretreated Patients with Relapsed or Refractory Multiple Myeloma Janssen
07-Jun-2022 Drug combination shows promise against cancer’s ‘death star’ protein The Institute of Cancer Research
07-Jun-2022 Coriolis Pharma Invests in Growth by Creating a New Campus in Martinsried-Munich Coriolis Pharma
07-Jun-2022 Screening of patients’ genomes for GPs to assess disease risk is ‘feasible’ The Institute of Cancer Research
07-Jun-2022 Sanofi grants Regeneron worldwide exclusive license rights to Libtayo® (cemiplimab) Sanofi
07-Jun-2022 4P-Pharma and Delta 4 Join Forces to Find and Develop Treatments for a Rare Autoimmune Chronic Liver Disease 4P-Pharma and Delta 4
07-Jun-2022 EVERSANA and Limitless Minds Advance Pharmaceutical Sales Performance with New Cognitive & Behavioral Training Solution EVERSANA
07-Jun-2022 OSE Immunotherapeutics SA: Four Poster Presentations at 2022 ASCO Annual Meeting Businesswire
07-Jun-2022 Sensorion Announces Approval in France to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation Businesswire
07-Jun-2022 Navigo Proteins Announces Launch of an Exclusive Affinity Resin for the Capture of gp64 Navigo Proteins
07-Jun-2022 Nordic Nanovector to Conduct a Comprehensive Review and Independent Data Evaluation of PARADIGME, its Phase 2b Trial with Betalutin® in R/R FL as a Result of Continuing Slow Recruitment Nordic Nanovector
07-Jun-2022 Major shareholder announcement for Genmab A/S Genmab
07-Jun-2022 PatientMetRx® launches Patient Opinion Mapping for fast, accurate and actionable insights PatientMetRx®
07-Jun-2022 NHS Chief receives CBE NHS England
07-Jun-2022 Lynred launches two multispectral linear array infrared detectors for future Earth observation mission applications Andrew Lloyd Associates
07-Jun-2022 Genexine reports encouraging top-line results of the Phase 1b/2 clinical trial with GX-I7 (efineptakin alfa) in refractory or recurrent (R/R) metastatic Triple Negative Breast Cancer Businesswire
07-Jun-2022 Feminine Hygiene Products Market value is estimated to CAGR of 7.0% during the forecast period by 2031 MARKITWIRED
07-Jun-2022 Adhesive Market Global Reach And Ultimately Achieve Greater Return On Investment By 2028 Market Research Community
07-Jun-2022 Cell Culture Media Market is expected to reach US$ 25.09 Billion in 2032 MARKITWIRED